Alterity Financial Group’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-9,346
Closed -$366K 74
2023
Q3
$366K Sell
9,346
-3,138
-25% -$125K 0.58% 47
2023
Q2
$507K Buy
12,484
+198
+2% +$8.15K 0.73% 38
2023
Q1
$514K Sell
12,286
-288
-2% -$12.1K 0.75% 40
2022
Q4
$548K Sell
12,574
-302
-2% -$12.8K 0.89% 36
2022
Q3
$500K Sell
12,876
-208
-2% -$8.86K 0.81% 37
2022
Q2
$555K Buy
+13,084
New +$568K 0.83% 37
2021
Q4
$710K Buy
+14,649
New +$693K 0.76% 41
2021
Q1
$624K Buy
+13,718
New +$650K 0.75% 39

Other funds holding BME

Alterity Financial Group's BME Position: Q4 2023 in Review

Alterity Financial Group sold out of BlackRock Health Sciences Trust (BME) in Q4 2023, closing a stake of 9,346 shares — an estimated $366K sold.

Alterity Financial Group first reported a position in BME in Q1 2021 and held it in 8 quarters. The position peaked at $710K in Q4 2021. 73 funds tracked by Wall St. Rank hold BME as of Q4 2023.

  • Alterity Financial Group reported no remaining BlackRock Health Sciences Trust position as of Q4 2023 after selling out during the quarter.
  • Alterity Financial Group sold 9,346 BlackRock Health Sciences Trust shares in Q4 2023, an estimated $366K.
  • Alterity Financial Group first reported a position in BlackRock Health Sciences Trust in Q1 2021 and held it in 8 quarters.
  • Alterity Financial Group's BlackRock Health Sciences Trust position peaked at $710K in Q4 2021.
  • 73 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2023.

Based on Alterity Financial Group's 13F filing for Q4 2023, filed 18 Jan 2024.